Chinese vaccines could fill the gap left by US and India, after WHO approval

file7fokwivj0q9byjr4gak

BEIJING, May 11. Global Times: The grave epidemic situation in India, the world's largest vaccine producer, the WHO's approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China could be a much more reliable global vaccine supplier, especially as domestic vaccine producers vowed to ramp up production to meet domestic immunity targets and overseas demand.

After the WHO approved the Sinopharm vaccine for emergency use, Yang Xiaoming, chairman of Sinopharm China National Biotec Group (CNBG), said in a recent interview with Chinese media outlets that the Chinese vaccine manufacturer has been ramping up efforts to expand production capacity in the third-phase of production to 3 billion doses per year.